Chidi Samuel| Nigeria’s coronavirus crisis shows no sign of abating as the country on Wednesday night recorded 587 new cases of the highly contagious virus.
The Nigeria Centre For Disease Control in a statement via its verified Twitter handle said the new infections were recorded in Lagos 155, Edo 75, FCT 67, Rivers 65, Oyo 56, Delta 50, Bayelsa 25, Plateau 18 and Kaduna 18.
Other centres of infections are, Enugu 17, Bornu 12, Ogun 12, Ondo 7, Kwara 4, Kano 2, Gombe 2, Sokoto and Kebbi recorded 1 case each.
According to the health agency, the total number of infections in the country stands at 17, 735, with 5, 967 discharges and 469 deaths.
The tweet read, 587 new cases of #COVID19Nigeria;
Lagos-155
Edo-75
FCT-67
Rivers-65
Oyo-56
Delta-50
Bayelsa-25
Plateau-18
Kaduna-18
Enugu-17
Borno-12
Ogun-12
Ondo-7
Kwara-4
Kano-2
Gombe-2
Sokoto-1
Kebbi-1
17,735 confirmed
5,967 discharged
469 deaths
-NCDC says breakthrough drug Dexamethsaone not approved by WHO
Meanwhile, The Nigeria Centre for Disease Control, NCDC, has reacted to the British government announcement of a cheap and widely available drug which it claimed has proved effective in saving patients seriously ill with COVID-19.
The British Prime Minister had on Tuesday said UK researchers identified a new drug, which is effective and has reduced COVID-19 deaths risk.
The scientists claimed that the drug identified as Dexamethasone has reduced death risk for patients in ventilators by one-third and oxygen by one fifth.
Reacting to the development, the NCDC in a tweet on its official Twitter handle, said the drug will not be used to treat patients because it has not been approved by the World Health Organization, WHO.
The tweet read, “The NCDC is aware of recent outcomes from a UK-Government funded clinical trial for COVID-19.
“The results support the use of Dexamethsaone as a possible treatment to reduce the risk of death among COVID-19 patients, who require oxygen or mechanical ventilation.
“Please note that the Government of Nigeria has not validated or approved any treatment for COVID-19.
“In addition, the use of Dexamethasone for COVID-19 treatment has not been validated by @WHO.”
Leave a Reply